Find VOWYGLHOVNSCSA-NRVKWRQJSA-N manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Qc4g8xs0h0, Fosravuconazole (l-lysine ethanolate), Fosravuconazole l-lysine ethanolate [mi], ((1r,2r)-2-(4-(4-cyanophenyl)-2-thiazolyl)-1-(2,4-difluorophenyl)-1-(1h-1,2,4-triazol-1-ylmethyl)propoxy) methyl ester compound with lysine, ethanolate (1:1:1), L-lysine, compd. with 4-(2-((1r,2r)-2-(2,4-difluorophenyl)-1-methyl-2-((phosphonooxy)methoxy)-3-(1h-1,2,4-triazol-1-yl)propyl)-4-thiazolyl)benzonitrile and ethanol (1:1:1), Fosravuconazole l-lysine ethanolate (jan)
Molecular Formula
C31H40F2N7O8PS
Molecular Weight
739.7  g/mol
InChI Key
VOWYGLHOVNSCSA-NRVKWRQJSA-N
FDA UNII
QC4G8XS0H0

VOWYGLHOVNSCSA-NRVKWRQJSA-N
1 2D Structure

VOWYGLHOVNSCSA-NRVKWRQJSA-N

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
[(2R,3R)-3-[4-(4-cyanophenyl)-1,3-thiazol-2-yl]-2-(2,4-difluorophenyl)-1-(1,2,4-triazol-1-yl)butan-2-yl]oxymethyl dihydrogen phosphate;(2S)-2,6-diaminohexanoic acid;ethanol
2.1.2 InChI
InChI=1S/C23H20F2N5O5PS.C6H14N2O2.C2H6O/c1-15(22-29-21(10-37-22)17-4-2-16(9-26)3-5-17)23(11-30-13-27-12-28-30,34-14-35-36(31,32)33)19-7-6-18(24)8-20(19)25;7-4-2-1-3-5(8)6(9)10;1-2-3/h2-8,10,12-13,15H,11,14H2,1H3,(H2,31,32,33);5H,1-4,7-8H2,(H,9,10);3H,2H2,1H3/t15-,23+;5-;/m00./s1
2.1.3 InChI Key
VOWYGLHOVNSCSA-NRVKWRQJSA-N
2.1.4 Canonical SMILES
CCO.CC(C1=NC(=CS1)C2=CC=C(C=C2)C#N)C(CN3C=NC=N3)(C4=C(C=C(C=C4)F)F)OCOP(=O)(O)O.C(CCN)CC(C(=O)O)N
2.1.5 Isomeric SMILES
CCO.C[C@@H](C1=NC(=CS1)C2=CC=C(C=C2)C#N)[C@](CN3C=NC=N3)(C4=C(C=C(C=C4)F)F)OCOP(=O)(O)O.C(CCN)C[C@@H](C(=O)O)N
2.2 Other Identifiers
2.2.1 UNII
QC4G8XS0H0
2.3 Synonyms
2.3.1 MeSH Synonyms

1. F-rvcz

2.3.2 Depositor-Supplied Synonyms

1. Qc4g8xs0h0

2. Fosravuconazole (l-lysine Ethanolate)

3. Fosravuconazole L-lysine Ethanolate [mi]

4. ((1r,2r)-2-(4-(4-cyanophenyl)-2-thiazolyl)-1-(2,4-difluorophenyl)-1-(1h-1,2,4-triazol-1-ylmethyl)propoxy) Methyl Ester Compound With Lysine, Ethanolate (1:1:1)

5. L-lysine, Compd. With 4-(2-((1r,2r)-2-(2,4-difluorophenyl)-1-methyl-2-((phosphonooxy)methoxy)-3-(1h-1,2,4-triazol-1-yl)propyl)-4-thiazolyl)benzonitrile And Ethanol (1:1:1)

6. Fosravuconazole L-lysine Ethanolate (jan)

7. Fosravuconazole L-lysine Ethanolate [jan]

8. 914361-45-8

9. L-lysine, Compd. With 4-[2-[(1r,2r)-2-(2,4-difluorophenyl)-1-methyl-2-[(phosphonooxy)methoxy]-3-(1h-1,2,4-triazol-1-yl)propyl]-4-thiazolyl]benzonitrile And Ethanol (1:1:1)

10. Unii-qc4g8xs0h0

11. E-1224 L-lysine Ethanolate

12. Bms-379224 L-lysine Ethanolate

13. Hy-16779b

14. Cs-0145609

15. D10762

16. Fosravuconazole L-lysine Ethanolate [who-dd]

17. (s)-2,6-diaminohexanoic Acid (((2r,3r)-3-(4-(4-cyanophenyl)thiazol-2-yl)-2-(2,4-difluorophenyl)-1-(1h-1,2,4-triazol-1-yl)butan-2-yl)oxy)methyl Dihydrogen Phosphate And Ethanol Salt

2.4 Create Date
2016-01-22
3 Chemical and Physical Properties
Molecular Weight 739.7 g/mol
Molecular Formula C31H40F2N7O8PS
Hydrogen Bond Donor Count6
Hydrogen Bond Acceptor Count17
Rotatable Bond Count15
Exact Mass739.23647576 g/mol
Monoisotopic Mass739.23647576 g/mol
Topological Polar Surface Area281 Ų
Heavy Atom Count50
Formal Charge0
Complexity967
Isotope Atom Count0
Defined Atom Stereocenter Count3
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count3

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.biospectrumasia.com/news/25/11326/eisai-to-bring-nailin-capsules-in-japan-.html

BIOSPACE
19 Jul 2018

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty